MAPT and Alzheimer disease: ApoE4-KI mice progressively develop hallmark AD-related neuropathological changes, including Aβ deposition, tau phosphorylation, synaptic loss, and gliosis, even in the absence of overt behavioral deficits in the early stages [20].